IRIS - Res&Arch Institutional Research Information System - Research & Archive

BIANCHI, Roberta
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 2.624
EU - Europa 2.354
AS - Asia 856
SA - Sud America 70
AF - Africa 21
Continente sconosciuto - Info sul continente non disponibili 4
Totale 5.929
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.613
IT - Italia 539
IE - Irlanda 393
UA - Ucraina 391
SG - Singapore 342
SE - Svezia 290
HK - Hong Kong 189
RU - Federazione Russa 188
VN - Vietnam 136
CN - Cina 129
DE - Germania 121
RO - Romania 111
FI - Finlandia 101
FR - Francia 86
BR - Brasile 66
GB - Regno Unito 32
CZ - Repubblica Ceca 29
BE - Belgio 25
CH - Svizzera 15
CI - Costa d'Avorio 14
TR - Turchia 14
GR - Grecia 11
UZ - Uzbekistan 11
KR - Corea 8
NL - Olanda 8
IN - India 7
AT - Austria 6
LB - Libano 6
MA - Marocco 5
MX - Messico 5
CA - Canada 4
EU - Europa 4
PL - Polonia 3
AR - Argentina 2
EC - Ecuador 2
JO - Giordania 2
PH - Filippine 2
AE - Emirati Arabi Uniti 1
CR - Costa Rica 1
EG - Egitto 1
HN - Honduras 1
HU - Ungheria 1
IQ - Iraq 1
IR - Iran 1
JP - Giappone 1
KG - Kirghizistan 1
LA - Repubblica Popolare Democratica del Laos 1
LK - Sri Lanka 1
LT - Lituania 1
LV - Lettonia 1
NG - Nigeria 1
OM - Oman 1
PT - Portogallo 1
QA - Qatar 1
SK - Slovacchia (Repubblica Slovacca) 1
TH - Thailandia 1
Totale 5.929
Salva come PNG Salva come JPEG
Città #
Chandler 427
Dublin 393
Perugia 326
Singapore 252
San Mateo 232
Jacksonville 191
Hong Kong 189
Boardman 157
Dong Ket 135
Santa Clara 113
Bucharest 111
Wilmington 97
Medford 94
Princeton 93
Altamura 89
Redmond 89
Ann Arbor 77
Andover 70
Des Moines 69
Lawrence 68
Beijing 56
Moscow 52
Falls Church 45
Dearborn 34
Woodbridge 27
Pisa 26
Saint Petersburg 26
Brussels 25
Ashburn 24
Norwalk 22
Brno 18
Fremont 16
Helsinki 16
New York 16
Abidjan 14
Los Angeles 14
San Paolo di Civitate 14
Dallas 12
The Dalles 12
Munich 11
Izmir 10
Olomouc 9
San Diego 9
Nuremberg 8
Milan 7
Seoul 7
Den Haag 6
Hanover 6
Shanghai 6
Nanjing 5
Redwood City 5
Nagpur 4
Tappahannock 4
Auburn Hills 3
Chengdu 3
Chicago 3
Curitiba 3
Falkenstein 3
Frankfurt Am Main 3
Jinan 3
Nichelino 3
Nürnberg 3
Ottawa 3
Paris 3
Spoleto 3
São Paulo 3
Turin 3
Amman 2
Belo Horizonte 2
Brasília 2
Camaçari 2
Cambridge 2
Campos dos Goytacazes 2
Caxias do Sul 2
Deruta 2
Edinburgh 2
Guangzhou 2
Handan 2
Houston 2
Joinville 2
Kunming 2
Lausanne 2
Ludwigshafen 2
Marrakesh 2
Mauá 2
Nanchang 2
Planegg 2
Pune 2
Rio De Janeiro 2
Saint Louis 2
San Jose 2
Shenyang 2
Silea 2
Stockholm 2
Tashkent 2
Terni 2
Vicenza 2
Wuhan 2
Zhengzhou 2
Abu Dhabi 1
Totale 3.945
Salva come PNG Salva come JPEG
Nome #
Class IA PI3Ks regulate subcellular and functional dynamics of IDO1 145
Allosteric modulation of metabotropic glutamate receptor 4 activates IDO1-dependent, immunoregulatory signaling in dendritic cells 143
Aryl hydrocarbon receptor control of a disease tolerance defence pathway. 137
Distinct roles of immunoreceptor tyrosine-based motifs in immunosuppressive indoleamine 2,3-dioxygenase 1. 137
A GpC-Rich Oligonucleotide Acts on Plasmacytoid Dendritic Cells To Promote Immune Suppression. 135
A Relay Pathway between Arginine and Tryptophan Metabolism Confers Immunosuppressive Properties on Dendritic Cells 129
Engagement of Nuclear Coactivator 7 by 3-Hydroxyanthranilic Acid Enhances Activation of Aryl Hydrocarbon Receptor in Immunoregulatory Dendritic Cells 123
Identification of a 2-propanol analogue modulating the non-enzymatic function of indoleamine 2,3-dioxygenase 1 119
Reverse signaling through GITR ligand enables dexamethasone to activate IDO in allergy 110
IL‐35Ig–expressing dendritic cells induce tolerance via Arginase 1 107
Positive allosteric modulation of indoleamine 2,3-dioxygenase 1 restrains neuroinflammation 100
Forced IDO1 expression in dendritic cells restores immunoregulatory signalling in autoimmune diabetes 95
Immunogenic tumor variants induced by drug treatment of the L5178Y lymphoma: search for serologically defined antigens at the clonal level. 94
A retroviral peptide encoded by mutated env p15E gene is recognized by specific CD8+ T lymphocytes on drug-treated murine mastocytoma P815. 92
87P - Towards the identification of the mechanism of action of antitumor 1-methyl-D-tryptophan 91
The TGF-β/IDO axis in infectious tolerance. 90
Cutting edge: Autocrine TGF-beta sustains default tolerogenesis by IDO-competent dendritic cells. 88
Dendritic cells expressing ectopic IL-35Ig induce IDO-related tolerance in vivo. 87
CD8+ cell activation to a major mastocytoma rejection antigen, P815AB: requirement for tum- or helper peptides in priming for skin test reactivity to a P815AB-related peptide 86
Indoleamine 2,3-dioxygenase is a signaling protein in long-term tolerance by dendritic cells 86
Aryl hydrocarbon Receptor and RelB control long term expression of Indoleamine 2,3-dioxygenase-1 in endotoxin tolerance 86
Preclinical discovery and development of fingolimod for the treatment of multiple sclerosis 86
Deficiency of immunoregulatory indoleamine 2,3-dioxygenase 1 in juvenile diabetes 86
CTLA-4-Ig activates forkhead transcription factors and protects dendritic cells from oxidative stress in nonobese diabetic mice 82
IL-12 acts selectively on CD8a- dendritic cells to enhance presentation of a tumor peptide in vivo 81
Antigen-specific immunoregulation by IL-35Ig-transfected dendritic cells 80
Islet antigen-pulsed dendritic cells expressing ectopic IL-35Ig protect nonobese diabetic mice from autoimmune diabetes. 77
Autocrine IL-12 is involved in dendritic cell modulation via CD40 ligation 76
Adoptive immunotherapy of intracerebral murine lymphomas: role of different lymphoid populations. 76
Ectopic expression of IL-35Ig by dendritic cells induces tolerance via Arginase 1. 74
IL-6 inhibits the tolerogenic function of CD8 alpha+ dendritic cells expressing indoleamine 2,3-dioxygenase. 73
Circulating levels of IL-10 are critically related to growth and rejection patterns of murine mastocytoma cells. 73
O6-alkylguanine-DNA alkyltransferase attenuates triazene-induced cytotoxicity and tumor cell immunogenicity in murine L1210 leukemia 72
Modulation of tryptophan catabolism by regulatory T cells 71
High doses of CpG oligodeoxynucleotides stimulate a tolerogenic TLR9-TRIF pathway. 69
CD28 induces immunostimulatory signals in dendritic cells via CD80 and CD86. 68
[Experimental models of immunochemotherapeutic synergism: study of the influence of the treatment schedule]. 68
Dendritic cells, interleukin 12, and CD4+ lymphocytes in the initiation of class I-restricted reactivity to a tumor/self peptide. 64
Drug-induced immunogenic changes of murine leukemia cells: dissociation of onset of resistance and emergence of novel immunogenicity. 64
CD40 ligand and CTLA-4 are reciprocally regulated in the Th1 cell proliferative response sustained by CD8+ dendritic cells. 61
T-cell subsets, IFN-gamma production and efferent specificity in anti-parental tumor immunity induced by mouse sensitization with xenogenized variant cells. 61
Systemic adoptive immunotherapy of a highly immunogenic murine lymphoma growing in the brain. 61
CTLA-4-Ig regulates tryptophan catabolism in vivo. 59
Ligand and cytokine dependence of the immunosuppressive pathway of tryptophan catabolism in plasmacytoid dendritic cells. 59
[Transfer in vivo of cytotoxic immune lymphocytes obtained in vitro in primary culture against a murine lymphoma antigenically altered by DTIC]. 59
Multiple point mutations in an endogenous retroviral gene confer high immunogenicity on a drug-treated murine 58
T cell apoptosis by tryptophan catabolism 58
Delayed-type hypersensitivity to tumor antigens co-expressed with immunogenic determinants induced by xenogenization. 58
Ectopic expression of IL-35Ig by dendritic cells induces IDO-related tolerance in vivo 58
A tumor-associated and self antigen peptide presented by dendritic cells may induce T cell anergy in vivo, but IL-12 can prevent or revert the anergic state 57
Functional plasticity of dendritic cell subsets as mediated by CD40 versus B7 activation. 57
IL-12 is both required and sufficient for initiating T-cell reactivity to a class I-restricted tumor peptide (P815AB) following transfer of P815AB-pulsed dendritic cells 57
Immunomodulatory properties of ribavirin in the mouse. 56
Towards the identification of a tolerogenic signature in IDO-competent dendritic cells 56
Immunobiological aspects of the nude mouse model relative to human cancer chemosensitivity tests. 56
The combined effects of tryptophan starvation and tryptophan catabolites down-regulate T cell receptor zeta-chain and induce a regulatory phenotype in naive T cells 54
Enhanced tryptophan catabolism in the absence of the molecular adapter DAP12 54
Immunogenic properties of retroviral protein p15E from drug-treated murine mastocytoma P815 53
Dendritic cells, CD4+ lymphocytes and IL-12 in an experimental model of antitumor immunotherapy 53
Tumor-specific L3T4+ and Lyt-2+ lymphocytes in mice primed to mutagenized cell variants. 53
CD40 ligation prevents onset of tolerogenic properties in human dendritic cells treated with CTLA-4-Ig. 53
IL-12 ACTS DIRECTLY ON DC TO PROMOTE NUCLEAR LOCALIZATION OF NF-kB AND PRIMES DC FOR IL-12 PRODUCTION 53
Cutting edge: silencing suppressor of cytokine signaling 3 expression in dendritic cells turns CD28-Ig from immune adjuvant to suppressant. 51
The Proteasome Inhibitor Bortezomib Controls Indoleamine 2,3-Dioxygenase 1 Breakdown and Restores Immune Regulation in Autoimmune Diabetes. 50
CD40 ligation ablates the tolerogenic potential of lymphoid dendritic cells 50
Use of a skin test assay to determine tumor-specific CD8+ T cell reactivity 49
A defect in tryptophan catabolism impairs tolerance in nonobese diabetic mice 48
IL-23 and IL-12 have overlapping but distinct effects on murine dendritic cells. 46
Endotoxin tolerance as a novel defense strategy in infectious diseases: the role of tryptophan catabolism 46
O6-methylguanine-DNA methyltransferase activity and induction of novel immunogenicity in murine tumor cells treated with methylating agents. 45
Dendritic cells and interleukin 12 as adjuvants for tumor-specific vaccines. 45
Molecular and genomic aspects of xenogenizing-alkylating drugs. 45
IL-12 induces SDS-stable class II (alpha beta) dimers in murine dendritic cells 44
Intracerebral adoptive immunotherapy of a murine lymphoma antigenically altered by drug treatment in vivo. 44
Murine plasmacytoid dendritic cells initiate the immunosuppressive pathway of tryptophan catabolism in response to CD200 receptor engagement 44
Immune system to brain signaling and vice versa: The role of tryptophan and glutamate 43
Inhibition of murine lymphoma growth by adoptive transfer of lymphocytes sensitized to a xenogenized tumor variant. 43
Functional expression of indoleamine 2,3-dioxygenase by murine CD8 alpha(+) dendritic cells. 42
Kynurenine pathway enzymes in dendritic cells initiate tolerogenesis in the absence of functional IDO. 42
Tryptophan catabolism generates autoimmune-preventive regulatory T cells 41
SOCS3 drives proteasomal degradation of indoleamine 2,3-dioxygenase (IDO) and antagonizes IDO-dependent tolerogenesis 41
Positive regulatory role of IL-12 in macrophages and modulation by IFN-gamma 40
T-cell subsets, IFN-gamma production and efferent specificity in anti-parental tumor immunity induced by mouse sensitization with xenogenized variant cells. 39
Tryptophan catabolism in nonobese diabetic mice. 39
Immunogenicity of tumor peptides: importance of peptide length and stability of peptide/MHC class II complex 38
Indoleamine 2,3-dioxygenase: from catalyst to signaling function 37
Induction of tumor suppression and delayed-type footpad reaction by transfer of lymphocytes sensitized to a xenogenized tumor variant. 37
PROTEASOME INHIBITION IN pDCs CONFERS AN IDO-DEPENDENT IMMUNOREGULATORY PHENOTYPE 32
IDO-TARGETING INTERVENTION IN AUTOIMMUNE DIABETES BY PROTEASOME INHIBITION 31
IFN-gamma inhibits presentation of a tumor/self peptide by CD8 alpha- dendritic cells via potentation of the CD8 alpha+ subset 30
Th1 and Th2 cell clones to poorly immunogenic tumor antigen initiate CD8+ T cell-dependent tumor eradication in vivo 29
Indoleamine 2,3 dioxygnenase: as an inducer and amplifier of regulatory T cell functions. 26
The role of IL-12 in the induction of an immune response to a tumor/self peptide: prevention and reversion of anergy. 26
Totale 6.187
Salva come PNG Salva come JPEG
Categoria #
all - tutte 26.310
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 26.310
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020141 0 0 0 0 0 0 0 0 0 56 23 62
2020/2021978 6 59 33 59 285 68 93 5 109 41 69 151
2021/20221.141 15 160 12 52 56 32 14 277 108 88 107 220
2022/20231.462 107 249 15 116 137 187 0 77 515 5 41 13
2023/2024559 35 85 15 9 3 9 150 17 50 12 63 111
2024/2025923 23 113 98 72 160 62 47 88 231 29 0 0
Totale 6.187